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Abstract
Background: Cell growth and proliferation are tightly connected to ensure that appropriately sized daughter cells
are generated following mitosis. Energy stress blocks cell growth and proliferation, a critical response for survival
under extreme conditions. Excessive oncogenic stress leads to p53 activation and the induction of senescence, an
irreversible state of cell-cycle arrest and a critical component in the suppression of tumorigenesis. Nutrient-sensing
and mitogenic cues converge on a major signaling node, which regulates the activity of the mTOR kinase.
Although transcriptional responses to energy and oncogenic stresses have been examined by many gene-
expression experiments, a global exploration of the modulation of mRNA translation in response to these
conditions is lacking.
Results: We combine RNA sequencing and ribosomal profiling analyses to systematically delineate modes of
transcriptional and translational regulation induced in response to conditions of limited energy, oncogenic stress
and cellular transformation. We detect a key role for mTOR and p53 in these distinct physiological states, and
provide the first genome-wide demonstration that p53 activation results in mTOR inhibition and a consequent
global repression of protein translation. We confirm the role of the direct p53 target genes Sestrin1 and Sestrin2 in
this response, as part of the broad modulation of gene expression induced by p53 activation.
Conclusions: We delineate a bimodal tumor-suppressive regulatory program activated by p53, in which cell-cycle
arrest is imposed mainly at the transcriptional level, whereas cell growth inhibition is enforced by global repression
of the translation machinery.
Keywords: cell proliferation and growth, mTOR, p53 signaling, ribosome profiling, senescence, translation
regulation
Background
Cell growth (increase in cell mass) and proliferation
(increase in cell number) are tightly coupled to ensure
that appropriately sized daughter cells are produced after
mitosis. In single-cell eukaryotes such as yeast, cell
growth and proliferation are mainly regulated by nutri-
ent-sensing pathways. In multicellular organisms, these
two processes are also regulated by growth and mitogenic
signals, which are integrated with the nutrient-sensing
pathways. These nutrient-sensing and mitogenic signals
converge on a critical node, which regulates the activity
of the highly conserved mTOR kinase [1]. Disregulated
cell growth and proliferation are two fundamental aspects
of tumorigenesis. It is therefore not surprising that pivo-
tal proto-oncogenes (for example, RAS, PI3K and Akt)
and tumor-suppressor genes (for example, PTEN, NF1
and LKB1) directly regulate the activity of the mTOR
pathway, and that elevated mTOR signaling has been
detected in a large proportion of human cancers [2,3].
Consequently, mTOR has emerged as a key target for the
treatment of cancer and a number of mTOR inhibitors
are being examined by clinical trials [4,5].
A major safeguarding role against cancer development is
played by the p53 tumor suppressor [6,7]. Excessive onco-
genic signaling (’oncogenic stress’) leads to the activation
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of p53 and to the induction of senescence, an irreversible
state of cell-cycle arrest [8,9]. Abrogation of the p53
pathway leads to senescence-bypass and progression to
neoplastic transformation [10]. The coupling of cell prolif-
eration and growth signals suggests a role for p53 in con-
trolling cellular growth. However, while the role of p53 in
arresting cell proliferation is very well established, its role
in arresting cell growth is much less documented. Recent
reports described cross-talks between p53 and mTOR
pathways [11,12].
Until recently, systems-level analysis of biological pro-
cesses was mainly limited to the transcriptomic layer. For
almost two decades now, gene-expression microarrays
have enabled large-scale exploration of transcriptional
modulation under various physiological conditions and in
response to numerous stresses. By contrast, systematic
exploration of the modulation of mRNA translation signif-
icantly lagged behind due to the lack of a genomic techni-
que that probes this regulatory layer. Very recently, a
deep-sequencing based technique called ribosome profil-
ing, or Ribo-Seq [13,14], was developed. It allows, for the
first time, the study - on a truly global scale - of changes
in rates of protein translation (Figure S1A in Additional
file 1).
In this study we combined RNA-Seq and Ribo-Seq ana-
lyses to systematically explore modes of transcriptional
and translational control in conditions of limited nutrients
(quiescence), oncogenic stress (senescence) and cellular
neoplastic transformation. Our results detect major pat-
terns of transcriptional and translational responses
induced by these stresses and indicate critical roles for
mTOR and p53 in their regulation.
Results
Patterns of transcriptional and translational regulation
associated with decreased cell growth and proliferation
We set out to explore, on genomic and transcriptomic
scales, cellular regulation of transcription and translation
associated with the modulation of cell growth and prolif-
eration. We therefore applied in parallel RNA-Seq and
Ribo-Seq analyses to immortalized human primary BJ
fibroblast cells under the following conditions: normal
proliferation; quiescence, induced by serum depletion;
senescence, induced by activation of the oncogenic
RASG12V gene, and examined at early (5 days; herein
referred to as pre-senescent state) and late (14 days; fully
senescent) time points; and neoplastic transformation,
induced by RASG12V in the background of stable p53
and p16INK4A knockdowns and SV40 small-T expression
(Figure 1A). (For details on this transformed cellular sys-
tem see [10].) Both RNA-Seq and Ribo-Seq measurements
showed a high degree of reproducibility (r >0.95) between
biological replicates that were measured on the same
sequencer run, whereas lower reproducibility was observed
between samples measured on different runs. Therefore,
each test condition was compared to the control sample
(cells grown under normal conditions) of the same batch
(Figure S1B,C,D in Additional file 1). In addition, Ribo-
Seq reads featured the expected location (markedly
depleted from 3′ untranslated regions (UTRs)) and frame
distribution (most reads started at frame 0 of the codons)
(Table S1 in Additional file 2). The subsequent analyses
included 9,686 transcripts covered by at least 40 reads in
both the RNA-Seq and Ribo-Seq datasets, in at least one
of the examined conditions.
To detect the major patterns of transcriptional and
translational regulation in our dataset, we filtered it for
transcripts that showed a change in either their expression
level or in their translational efficiency (TE) across the
examined conditions (Materials and methods; Figure S1E
in Additional file 1), and then subjected this set of tran-
scripts to cluster analysis (Figure 1 and Table S2 in Addi-
tional file 3). The majority of clusters showed remarkably
symmetric responses between the RNA-Seq and Ribo-Seq
measurements (Figure 1B,C, annotated red and blue,
respectively). The genes assigned to these clusters were
regulated at the RNA level (namely, regulated mainly at
transcriptional level and, possibly, to some extent also sub-
ject to regulation of transcript stability), and they demon-
strated the expected mirroring and transmission of
transcript level modulation to rates of protein translation.
This high correlation between measurements obtained by
these very different techniques (RNA-Seq and Ribo-Seq)
attests the competence of Ribo-Seq in faithfully recording
rates of protein translation.
Analysis of the clusters representing patterns of RNA
induction (Figure 1B) showed that transcripts induced
specifically in response to nutrient depletion were signif-
icantly enriched for genes that function in steroid bio-
synthesis (Figure 1B, cluster RNA_up#1. The major
transcriptional regulators of the genes that function in
this metabolic pathway are sterol-regulatory element
binding transcription factor 1 and 2 (SREBF1/2) [15];
both were contained in this cluster (transcript levels of
SREBF1 and SREBF2 were induced in quiescence by
2.5- and 3.8-fold, respectively), and their induction
resulted in a vast up-regulation of enzymes that function
along this pathway (Figure S2 in Additional file 1). The
induction of the steroid biosynthesis pathway in quies-
cence is likely aimed at producing endogenous lipids in
the absence of their exogenous supply.
Transcripts that were specifically induced in the senes-
cent state were enriched for p53 targets (Figure 1B, cluster
RNA_up#2; for example, CDKN1A (p21), GADD45A,
TP53I3), demonstrating the strong activation of p53, the
key inducer of senescence (for example, p21 was induced
by more than 4-fold). Genes related to cytokine activity
were over-represented in the gene clusters induced either
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specifically in the transformed state (Figure 1B, cluster
RNA_up#3) or in both the senescent and transformed
ones (Figure 1B, cluster RNA_up#4). In our experimental
setup, these two states were driven by expressing of
RASG12V, which causes cellular ‘hyper-function’, one man-
ifestation of which is hyper-secretion of inflammatory-
related genes [16]. Cluster RNA_up#5 contained genes
that were strongly induced both in the quiescent and
senescent states (and to a lesser extent in pre-senescence),
but were not induced in the transformed one. That is,
these genes were induced in the stressed conditions that
lead to attenuated proliferation, prominent among them
were Sestrin2 (SESN2) and Polo-like kinase 3.
Four major patterns of RNA repression were detected
in our dataset (Figure 1C). The most prominent among
them contained more than 340 transcripts that were vig-
orously repressed in senescence and to a lesser extent in
quiescence (Figure 1C, cluster RNA_down#1). This clus-
ter was overwhelmingly enriched for cell-cycle genes,
reflecting the block in cell-cycle progression imposed by
serum starvation (quiescence) or RASG12V activation in
the presence of functional p53 (senescence). This cluster
Figure 1 Wide-scale exploration of patterns of transcriptional and translational regulation in response to energy and oncogenic
stresses using RNA-Seq and Ribo-Seq. (A) We profiled gene-expression levels (RNA-Seq) and rates of mRNA translation (Ribo-Seq) in human
primary fibroblast BJ cells subjected to serum depletion (energy stress which results in quiescence (Q) or induction of RASG12V (oncogenic stress
which results in senescence (S) in the presence of functional p53, and in neoplastic transformation (T) in the absence of functional p53 and
p16INK4A). We examined the effect of RASG12V at two time points, 5 days (pre-senescence; preS) and 14 days (senescence; S). (B-D) Transcripts
that showed either differential expression or differential translation efficiency (TE) were identified in the combined RNA-Seq and Ribo-Seq dataset
and subjected to cluster analysis. Major patterns of RNA induction (B), RNA repression (C) and modulation of TE (D) were detected. Each cluster
is represented by the mean pattern of its assigned transcripts (error bars represent ±SD). The first five points (red) represent transcript levels and
the subsequent five points (blue) represent mRNA translation levels. Prior to clustering, levels measured for each transcript were standardized to
mean = 0 and SD = 1 (so transcripts that are clustered together show similar response pattern in our dataset but might differ in the magnitude
of their response). Enriched functional categories (P-value calculated using hypergeometric tail) and selected genes are indicated next to the
patterns. C, control.
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also reflects how the absence of p53 and p16INK4A com-
pletely abrogates the induction of cell-cycle arrest in the
face of oncogenic RAS (no repression of cell-cycle genes
was observed in the transformed condition). The next
cluster contained genes that were repressed in quiescent
and to a lesser extent in senescence (Figure 1C, cluster
RNA_down#2), and it was significantly enriched for
genes that function in ribosome biogenesis, a critical
node for regulation of cell growth. Among these genes
were BOP1, a component of the PeBow complex that is
required for pre-ribosome association; EBNA1BP2, a
nuclear matrix protein that form a dynamic scaffold for
ribosome biogenesis in the nucleolus; NOP56, which is
required for assembly of the 60S ribosomal subunit; and
PA2G4, which is present in pre-ribosomal ribonucleo-
protein complexes and is involved in ribosome assembly
and the regulation of intermediate and late steps of
rRNA processing. The next clusters contained genes
that were repressed in either senescence or the trans-
formed state, and were enriched, respectively, for extra-
cellular matrix and adhesion proteins (Figure 1C,
clusters RNA_down#3 and RNA_down#4).
In addition to patterns of transcriptional modulation,
the combined RNA-Seq and Ribo-Seq dataset also
revealed major patterns of translational modulation
(namely, changes in rates of protein translation that do
not simply mirror changes occurring at the transcript
level) that are associated with the physiological states of
quiescence, senescence and transformation (Figure 1D).
Two main patterns of induction of TE and two of TE
repression were identified. Notably, the clusters of TE
repression revealed one of the strongest responses in
our dataset: a global repression of the translation of vir-
tually all the ribosomal proteins (of both the large and
small ribosome subunits) and of key factors that func-
tion in the initiation, elongation and termination steps
of protein translation (Figure 1D, clusters Translation_-
down #1 and #2). This systematic translational repres-
sion of ribosomal protein and translation-factor
transcripts, which blocks cellular growth, was strongest
in quiescence but was also significantly observed in
senescence. Importantly, the absence of functional p53
and p16INK4A (the transformed state) did not only abol-
ish the activation of proliferation arrest (Figure 1C, clus-
ters RNA_down#1) but also completely abrogated the
activation of the cell-growth arrest program in response
to oncogenic stress.
Two modes of regulation of the translation apparatus
Examination of the major patterns detected in our data-
set suggested that, in response to energy stress (serum
depletion), the cells activated a double-armed regulatory
program to achieve global attenuation of protein synth-
esis and thereby arrest cell growth. One arm of this
program imposed transcriptional repression of genes
that function in ribosome biogenesis (for example,
rRNA processing and assembly of the ribosome) (Figure
1C, cluster RNA_down#2), while the second arm
enforced repression of the translation of the ribosomal
proteins themselves and of key translational factors (Fig-
ure 1D, clusters Translation_down #1 and #2). To test
this hypothesis more systematically, we compared how
genes functionally annotated as playing a role in ribosome
biogenesis (Gene Ontology (GO) term GO:0042254, 120
genes) and the ribosomal protein genes (99 genes) were
regulated in our dataset. This comparison clearly showed
a distinct mode of regulation during energy stress: while
the ribosomal protein genes were regulated exclusively at
the layer of translation (Figure 2A), ribosome-genesis
genes were mainly regulated at the transcriptional level.
Next, we used the SPIKE knowledgebase of signaling
pathways [17] to build a comprehensive map of the pro-
tein-translation apparatus, and used this map to demon-
strate the bimodal regulation of the translational
machinery in response to energy stress. The two func-
tionally distinct modules of this machinery, comprising
the auxiliary ribosome-genesis genes on the one hand
and the ribosomal proteins and translation initiation,
elongation and termination factors on the other, were
clearly regulated at distinct, yet highly coordinated, reg-
ulatory layers - the former functional module was
mainly regulated at the transcriptional level, whereas the
latter was regulated at the mRNA translational level
(Figure 2B).
Translational repression of the translation machinery is a
molecular hallmark of mTOR inhibition
Recently, Hsieh et al. [18] applied the combined RNA-
Seq and Ribo-Seq approach to prostate cancer cells trea-
ted with two mTOR inhibitors: rapamycin, which is an
allosteric mTOR inhibitor, and PP242, which is a more
potent inhibitor that interferes with mTOR’s ATP site.
Analyzing this dataset, we identified only one major pat-
tern of translation modulation in response to mTOR
inhibition. This pattern included more than 150 tran-
scripts whose TE was repressed in response to PP242
and, to a lesser extent, rapamycin (Figure S3A in Addi-
tional file 1). This cluster was overwhelmingly enriched
for components of the translational apparatus and
included virtually all the ribosomal proteins and major
translation initiation, elongation and termination factors
(Figure S3B in Additional file 1). To statistically examine
the effect of mTOR inhibition on the TE of the riboso-
mal proteins, we compared the change in TE observed
for the set of ribosomal protein transcripts to that
observed for all the other protein-coding transcripts
detected in this dataset. Indeed, ribosomal proteins’ TE
was strikingly attenuated after treatment with either of
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Figure 2 Two modes of regulation of the translation apparatus. (A) We examined changes in transcript levels (top) and in translation
efficiency (TE; bottom), in each condition relative to control proliferating cells, of two functional modules of the translational apparatus:
ribogenesis genes (left) and ribosomal protein genes (right). P-values were calculated for each condition by comparing changes observed for the
test gene-set and for a background set containing all the other transcripts in the dataset; Wilcoxon test. The figure shows that while the
ribosomal protein genes were strikingly and exclusively regulated at the layer of mRNA translation, regulation of ribogenesis genes was enforced
at the transcriptional level, and to a lesser extent, in some conditions also at the level of translation. (B) A comprehensive map of the
translational apparatus generated using the SPIKE knowledgebase of signaling pathways. The map contains five types of nodes (violet nodes
represent genes/proteins; green, protein complexes; yellow, gene families; pink, biological functions or states (for example, ‘translation
elongation’); and orange, signaling molecules (for example, AMP)), and two types of edges (blue edges represent regulatory relationship
between nodes; arrow for activation and T-shaped edges for inhibition; green edges represent associations between gene families or protein
complexes and their members). Genes that were repressed in response to energy stress (quiescence state) in our dataset at the transcriptional or
the translational levels are colored, respectively, by orange or brown bars to the left of their nodes. (Red and green dots within nodes indicate
that the nodes have additional regulation and association relationships in the in SPIKE database that are not displayed in the map to reduce
clutter).
Loayza-Puch et al. Genome Biology 2013, 14:R32
http://genomebiology.com/2013/14/4/R32
Page 5 of 12
the two mTOR inhibitors (Figure S3C in Additional
file 1). These results indicate that global translational
repression of the cellular translation machinery is a
molecular hallmark of mTOR inhibition. This suggests
that the comprehensive repression of ribosomal proteins
observed in both the quiescent and senescent states
(Figure 2A) was mediated through inhibition of the
mTOR pathway.
mTOR inhibition in conditions of energy stress is very
well established, whereas the inhibition of this pathway
in the face of oncogenic stress is much less documented.
To gain insights into the mechanism by which the
translation of the translational apparatus is regulated,
we searched for enriched motifs in the 5′- and 3′-UTR
of the transcripts detected in this module. In accordance
with previous publications, we found that the 5′-UTRs
of these transcripts were significantly enriched for a
T/C-rich motif (Figure S3D in Additional file 1), which
corresponds to the 5′-terminal oligopyrimidine tract (5′-
TOP) element that was previously demonstrated to con-
trol the translation of the majority of ribosomal proteins
and many key translation factors [19-21].
p53-mediated attenuation of cell proliferation and
growth
While RASG12V induction in the presence of functional
p53 results in senescence, its activation in the background
of compromised p53 and p16INK4A leads to the develop-
ment of neoplastic transformation. As discussed above,
our parallel global profiling of transcript and translation
levels showed that among the main responses that were
imposed by the cells in senescence but not in the trans-
formed state were attenuation of cell-cycle progression
(regulated at the layer of transcripts level; Figure 1C, clus-
ter RNA_down#1) and of cell growth (regulated at the
layer of mRNA translation; Figure 1D, cluster Transla-
tion_down #1). While induction of cell-cycle arrest is one
of the most well characterized functions of p53, its role in
the regulation of cell growth is less documented. There-
fore, we next globally characterized the effect of p53 acti-
vation on transcript expression and mRNA translation.
We treated immortalized BJ cells with nutlin-3a, an inhibi-
tor of MDM2 and a potent inducer of p53 [22], and
applied RNA-Seq and Ribo-Seq to these samples.
As expected, nutlin-3a treatment resulted in a very strong
induction of a set of p53 target genes (Figure S4 in
Additional file 1), and this activation resulted in a sharp
down-regulation of the expression of cell-cycle genes
(Figure 3A). Most importantly, in addition to modulation
of transcript levels, we also revealed that p53 activation
resulted in a striking translational repression of the riboso-
mal proteins and other key translation factors (Figure 3B).
We validated this result using standard polysome-fractio-
nation assay followed by RT-PCR of two top regulated
ribosomal genes; RPL34 and RPL23. In contrast to the
housekeeping gene GAPDH, whose mRNA association
with polysomes was not altered following nutlin-3a treat-
ment, both RPL genes showed a clear transcript shift
from polysome-associated to ribosome-free fractions
(Figure 3C). This result confirms the observed reduced TE
of the ribosomal transcripts following p53 activation.
Next, to corroborate our observations and elucidate
mechanisms by which p53 affects translation, we exam-
ined a second cell line, the MCF-7 breast cancer epithelial
cell line that contains wild-type p53. We applied RNA-Seq
and Ribo-Seq to examine MCF-7 transcriptional and
translational responses to Nulin-3a treatment. As in the
case of BJ fibroblasts, p53 activation by nutlin-3a in MCF-
7 cells resulted in a transcriptional strong down-regulation
of cell-cycle genes and broad translational repression of
the ribosomal protein and translation factors (Figure S5 in
Additional file 1). Thus, the p53-mediated translational
repression of the ribosomal proteins and translation fac-
tors seems a broad phenomenon.
We subsequently sought mechanisms by which p53
exerts its translational-repressive effect. It was previously
reported that p53 controls mTOR function through direct
activation of SESN1 and SESN2 [11]. To examine the role
of Sestrin-1 and -2 in mediating the translational repres-
sion of the translation machinery upon p53 activation, we
carried out an RNA-Seq and Ribo-Seq analysis of nutlin-
3a-treated and control MCF-7 cells in which both SESN1
and SESN2 were knocked-down. RNA-Seq and the Ribo-
Seq measurements confirmed efficient knockdown of both
Sestrin genes (Figure 4B). In line with our expectations,
knocking-down the Sestrin genes significantly compro-
mised the p53-induced translational repression of the
genes encoding the translation machinery (Figure 4C).
Thus, our results pinpoint the Sestrin genes as essential
mediators of the p53-mediated global repression of trans-
lation, and position mTOR activity in between active p53
and its global effect on the translational machinery.
Altogether, our results demonstrate that activation of
p53 leads to the simultaneous induction of two tumor-
suppressive programs: blocking cell proliferation and
arresting cell growth (Figure 5). While the first arm of
this bimodal response was strongly detected by the
many gene-expression microarray studies that examined
p53 responses, the second component was completely
overlooked by those studies as it is largely imposed at
the layer of translational regulation.
Discussion
We explored on a genomic- and transcriptomic scale
modulation of mRNA levels and their translation rates
in physiological conditions of energy deprivation, onco-
genic stress and neoplastic transformation. Two major
responses that were activated in response to energy and
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Figure 3 Bimodal p53-mediated suppression of cell proliferation and growth. (A) Examination of the effect of energy and oncogenic
stress, p53 activation by nutlin-3a (6 h and 19 h after treatment) and mTOR inhibition (by PP242 and rapamycin) on the expression level of cell-
cycle related transcripts. p53 activation resulted in a very significant attenuation of the expression of cell-cycle genes. P-values were calculated
for each condition by comparing the distribution of fold-change measured for cell-cycle and all the other genes in the dataset using Wilcoxon
test. We included in this analysis a subset of 298 genes selected from the set of GO cell-cycle genes (GO:007049) which showed a variation of at
least 1.5-fold in expression level (either induction or repression) across our entire dataset. (B) Examination of the effect of energy and oncogenic
stress, p53 activation by nutlin-3a and mTOR inhibition on the translation efficiency of the ribosomal protein transcripts. p53 activation resulted
in a very significant repression of the translation of ribosomal gene transcripts (P-values were calculating as in A). (C) Validation of the effect of
p53 activation on translation efficiency of ribosomal gene transcripts measured by their ribosome occupancy. MCF-7 cells were treated with
nutlin-3a for 20 h and subjected to isolation of polysome-associated mRNAs (see Methods). Polysomal fractionation followed by RT-PCR for two
ribosomal genes (and GAPDH as a control) were used to quantify mRNA levels in the different polysomal fractions.
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oncogenic stresses but not in the transformed state were
the suppression of cell-cycle genes and the inhibition of
translational machinery genes. The former represents
attenuation of cell proliferation and the latter attenua-
tion of cell growth. Interestingly, while cell-cycle regula-
tion was observed solely at the transcript level, a two-
armed program was induced to attenuate protein trans-
lation and thereby suppress cell growth. The ribosomal
proteins and key translational factors were repressed
exclusively at the level of mRNA translation, while the
auxiliary genes encoding for proteins that function in
rRNA processing and ribosome assembly were mainly
down-regulated at the level of transcript expression
(Figure 2). In agreement with our observation, a recent
study demonstrated a link between mTOR signaling and
the transcriptional regulation of ribosome biogenesis
genes [23].
Inhibition of the translational machinery is a critical
response in the face of stress because protein biosynth-
esis is the most energy-demanding process in the cell.
mTOR is a master regulator of protein synthesis [1], and
its inhibition results in global translational repression of
the translational machinery (Figure S3 in Additional file
1; [18]). The 5′-UTRs of the translationally repressed
transcripts were significantly enriched for the 5′-TOP
motif that was demonstrated to control their TE. The
mechanisms by which the translation of 5′-TOP tran-
scripts is regulated have remained elusive for a long time
and are still under intensive investigation. Recently, Dam-
gaard et al. [24] reported that the TIA-1 and TIAR RNA-
binding proteins are assembled on the 5′-end of 5′-TOP
transcripts in response to serum starvation and that this
association, which was dependent on inactivation of the
mTOR pathway, blocks the translation of the target
Figure 4 Knocking-down the Sestrin genes significantly compromises the translational repression of the translation machinery upon
p53 activation. (A) A table showing fold induction of Sestrin1 and Sestrin2 (SESN1 and SESN2, respectively) in nutlin-3a treated cells for the
indicated times compared to control untreated cells. (B) MCF-7 cells were transfected with si-control and si-SESN1 and si-SESN2 siRNA oligos,
treated with nutlin-3a for 20 h, and subjected to RNA-Seq and Ribo-Seq analyses. The effect of siRNAs on the RNA level and ribosome
occupancy of SESN1 and SESN2 is shown. (C) Comparison between changes in translation efficiency measured for genes encoding the
translational machinery (ribosomal proteins and translation initiation/elongation factors) in response to nutlin-3a treatment, in cells knocked-
down for Sestrin1 and Sestrin2 (right) or treated with control siRNAs (left). P-values calculated using Wilcoxon test. FPKM, fragments per kilobase
of mRNA per million reads; si, small interfering.
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transcripts at the initiation step. Thoreen et al. [25], how-
ever, did not find evidence for the involvement of TIA-1
or TIAR in the regulation of 5′-TOP transcripts, and
alternatively suggested that the translation of 5′-TOP
mRNAs is especially dependent on the interaction
between eIF4G1 and eIF4E initiation factors, which is
inhibited by the 4E-BP proteins (see map in Figure 2B).
The translation of 5′-TOP mRNAs is enhanced by
mTOR-mediated phosphorylation of the 4E-BP inhibi-
tory proteins; in conditions of stress, when mTOR path-
way activity is low, 4E-BP proteins bind eIF4E and
interfere with its interaction with eIF4G1, thereby selec-
tively attenuating the TE of 5′-TOP transcripts.
Excessive oncogenic signaling activates p53 and induces
senescence. Activation of cell-cycle arrest is one of the
best characterized tumor-suppressive functions of p53.
The observation that both cell-cycle genes and transla-
tional machinery transcripts were strongly repressed in
senescence (at the transcriptional and translational layers,
respectively), but not in the transformed state in which
p53 is knocked-down, suggested that p53 activation also
strongly inhibits cell growth. We tested this hypothesis by
examining the transcriptional and translational responses
induced by p53 activation following nutlin-3a treatment.
In line with our expectation, p53 activation resulted in a
striking translational repression of the translational
machinery (Figure 3B). Global translation repression of
the translational machinery is a hallmark of mTOR inhibi-
tion. This strongly suggests that the repression of the
translational machinery upon p53 activation is mediated
by inhibition of the mTOR pathway. Supporting this con-
clusion, we have demonstrated that p53 induction inhibits
the phosphorylation of 4E-BP1, a major mTOR target pro-
tein. Budanov and Karin [11] reported that two direct tar-
gets of p53, Sestrin1 and Sestrin2, mediate p53 inhibition
of the mTOR pathway by activating AMP-responsive pro-
tein kinase, which is also the main regulator that attenu-
ates mTOR signaling in response to energy stress (see
map in Figure 2B). Notably, both Sestrin1 and Sestrin2
were strongly induced in our dataset in response to
nutlin-3a treatment, and their inhibition allowed the accu-
mulation of phosphorylated 4E-BP1 in the presence of
high p53 levels (Figure 4A). Furthermore, knocking-down
the Sestrin genes significantly attenuated the translational
repression of the translation machinery in response to p53
activation (Figure 4C). Taken together, our results eluci-
date, for the first time on a global scale, the extensive
impact that p53 activation has on the translation machin-
ery, and demonstrate the role of Sestrin1 and 2 in inhibit-
ing mTOR activity upon p53 activation.
Senescence is usually described as a barrier to tumor
development. Recently, Blagosklonny and his colleagues
reported that p53 activation paradoxically repressed
senescence and converted it into quiescence [26]. A ser-
ies of follow-up studies demonstrated that the choice
between p53-induced senescence and quiescence is
determined by the activity of the mTOR pathway, where
low mTOR activity results in quiescence and higher
activity in senescence [27-31]. Accordingly, Blagosklonny
recently sharpened the characterization of the senescent
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Figure 5 Schematic model for the bimodal regulatory program activated by p53 to suppress cell growth and proliferation.
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phenotype as a state in which contradicting excessive
growth stimulatory and cell-cycle arrest signals coexist in
the cell. It is the cell-cycle arrest signals induced by p53
that pose the barrier to tumorigenesis, and not the senes-
cent state per se [32]. Our results support this model, and
delineate the bimodal regulatory program induced by
p53 to enforce concomitant block of both cell prolifera-
tion and growth as two coordinated responses that sup-
press neoplastic transformation.
Our understanding of control mechanisms that transla-
tionally co-regulate target mRNAs is scanty and very limited
compared to our knowledge on cis-regulatory promoter
elements that dictate transcriptional co-regulation of their
target genes. The 5′-TOP motif provides one glaring exam-
ple of a translational co-regulation mechanism. The advent
of the Ribo-Seq technique holds great promise for systema-
tic discovery of many more such mechanisms in the coming
years, similar to the major advance in the discovery of pro-
moter regulatory elements that followed the maturation of
expression arrays more than a decade ago.
Conclusions
We delineated a bimodal tumor-suppressive regulatory
program activated by p53, in which cell-cycle arrest is
imposed mainly at the transcriptional level, whereas cell




Immortalized human BJ primary fibroblast cells (by
human telomerase reverse transcriptase expression)
were cultured in Dulbecco’s modified Eagle’s medium
supplemented with 10% heat-inactivated fetal calf serum
in 5% CO2 at 37°C. Retroviruses were made by transient
transfection of Ecopack 2 cells (Clontech Laboratories,
Inc., Palo Alto, CA, USA) using calcium-phosphate pre-
cipitation and harvesting 40 and 64 h later. BJ cells were
selected with the proper selection medium 48 h after
transduction for at least a week. To obtain pre-senescent
and senescent datasets, BJ cells expressing human telo-
merase reverse transcriptase and tamoxifen-inducible
RASG12V were cultured in the presence of 10-7 M 4-
OHT-tamoxifen for 5 and 14 days, respectively. For the
transformed dataset, BJ cells expressing human telomer-
ase reverse transcriptase, p16INK4A-Knock-Down (KD)
p53-KD and SV40 small-T were retrovirally transduced
with pBabe-puro-RASG12V. For p53 activation, cells were
treated with nutlin-3a (8 mM, Cayman Chemicals, Ann
Arbor, MI, USA) for 6 and 19 h. MCF-7 cells were cul-
tured in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal calf serum. ON-TARGET plus
smartPOOL small interfering RNAs (siRNAs) against
SESN1 and SESN2 were purchased from Dharmacon
(Lafayette, CO, USA). MCF-7 cells were transfected
using Dharmafect 1 reagent (Dharmacon) following the
manufacturer’s instructions. For inhibition of mTOR,
MCF-7 cells were treated with 250 nM of Torin 1
(Tocris Bioscience, Bristol, UK) for 2 h.
Constructs
pRetrosuper (pRS) was described in [33]. pBabe-puro-
RasV12, pBabe-puro-RasV12ERTAM, pMSCV-GFP-st,
pBabe-H2B-GFP, pRS-p53 and pRS-p16 were described
in [10,34].
Ribosome profiling (Ribo-Seq)
Cells were treated with cycloheximide (100 μg/ml) for 8 to
10 minutes, washed with ice-cold phosphate-buffered sal-
ine (cycloheximide, 100 μg/ml), pelleted, and lysed in buf-
fer A (20 mM Tris-HCl, pH 7.8, 100 mM KCl, 10 mM
MgCl2, 1% Triton X-100, 2 mM DTT, 100 μg/ml cyclo-
heximide, 1X complete protease inhibitor). Lysates were
centrifuged at 5,000 rpm and the supernatant was treated
with 2 U/μl of RNase I (Invitrogen, Grand Island, NY,
USA) for 40 min at room temperature. Lysates were frac-
tionated on a linear sucrose gradient (7% to 47%) using
the SW-41Ti rotor at 36,000 rpm for 2 h. Fractions
enriched in monosomes were pooled and treated with pro-
teinase K (Roche, Mannheim, Germany) in a 1% SDS solu-
tion. Released RNA fragments were purified using Trizol
reagent and precipitated in the presence of glycogen. For
libraries preparation, RNA was gel-purified on a denatur-
ing 10% polyacrylamide urea (7 M) gel. A section corre-
sponding to 30 to 33 nucleotides, the region where most
of the ribosome-protected fragments are comprised, was
excised, eluted and ethanol precipitated. The resulting
fragments were 3′-dephosphorylated using T4 polynucleo-
tide kinase (New England Biolabs Inc. Beverly, MA, USA)
for 6 h at 37°C in 2-(N-morpholino)ethanesulfonic acid
(MES) buffer (100 mM MES-NaOH, pH 5.5, 10 mM
MgCl2, 10 mM b-mercaptoethanol, 300 mM NaCl). 3′
adaptor was added with T4 RNA ligase 1 (New England
Biolabs Inc. Beverly, MA, USA) for 2.5 h at 37°C. Ligation
products were 5′-phosphorylated with T4 polynucleotide
kinase for 30 min at 37°C. 5′ adaptor was added with T4
RNA ligase 1 for 18 h at 22°C.
Analysis of RNA-Seq and Ribo-Seq datasets
All samples were sequenced using Illumina’s HiSeq-2000
platform (Ilumina Inc, San Diago, CA, USA), with read
length of 50 nucleotides (see samples definition in Table
S1 in Additional file 2; all raw sequence data are deposited
at GEO; accession number [GSE:45833]). Sequenced reads
were aligned to a reference set of human curated protein-
coding transcripts (plus the five human rRNA transcripts)
using Bowtie [35]. This reference set was based on
Ensembl’s gene annotations (release 65). For genes with
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multiple isoforms, the one with longest coding DNA
sequence region and, in case not unique, the one with
longest UTR among the ones with the longest coding
DNA sequence, was selected to represent the gene. For
mapping of RNA-Seq reads, default Bowtie parameters
were used with setting -E to 150, which allows up to five
mismatches. For Ribo-Seq read mapping, the first 25
nucleotides were used as the ‘seed’. Only uniquely mapped
reads were used in subsequent analyses. The biological
samples that we analyzed together with some global statis-
tics on the alignments are summarized in Table S1 in
Additional file 2. As expected, Ribo-Seq reads were mark-
edly depleted from 3′UTRs, and showed characteristic dis-
tribution over the transcript reading-frame (Table S1 in
Additional file 2). Transcript expression and translation
levels were estimated by calculating fragments per kilobase
of mRNA per million reads (FPKM) measures per tran-
script, taking into account either all the reads that map to
the transcript (for estimation of expression levels using
RNA-Seq data) or only those which map to its coding
DNA sequence (for estimation of translation level). FPKM
levels below 1.0 were set to 1.0. Both RNA-Seq and Ribo-
Seq FPKM measurements were highly reproducible, both
showing correlation above 0.95 for biological replicates
sequenced on the same sequencer run (Figure S1B in
Additional file 1). The correlation between biological repli-
cates processed on different Ribo-Seq runs was lower but
still very high (r = 0.82; Figure S1C in Additional file 1).
Transcript TE was calculated per condition as the ratio
between transcript translation and expression levels (in
log2). RNA-Seq and Ribo-Seq data from the study of
Hsieh et al. [18] that examined responses to mTOR inhibi-
tion were downloaded from GEO (accession number
[GSE:45833]) and analyzed in the same way.
To detect the major response patterns in our dataset, we
first searched for transcripts that showed either differential
expression or differential TE in the examined conditions
relative to the control proliferating samples. Since we
observed a sequencer-run ‘batch effect’ (Figure S1D in
Additional file 1), we compared each test condition to the
control sample profiled in the same run (defined in Table
S1 in Additional file 2). As variation is larger among lowly
expressed transcripts, we set a dynamic cut-off depending
on expression level or translation levels (Figure S1E in
Additional file 1). A total of approximately 2,800 tran-
scripts passed the cut-off and were subjected to clustering.
Clustering and GO enrichment analyses were done using
the EXPANDER package [36]. De novo motif analysis was
done using AMADEUS [37]. All other statistical analyses
were done in R.
Isolation of polysome-associated mRNA
Cells were lysed in buffer A containing 1 U of Rnase-
OUT (Invitrogen, Grand Island, NY, USA). Lysate was
homogenized using a 26 G needle, and the cytosolic
extract was obtained by centrifugation at 1,300 g for
10 min. The extract was overlaid on a 7% to 47% linear
sucrose gradient and centrifuged in a SW41Ti rotor
(Beckman Coulter, California, USA) at 36,000 rpm for
2 h at 4°C. Twelve fractions were collected from the gra-
dients and RNA was isolated from each using Trizol
reagent. Reverse transcription was performed using
GoScript Reverse Transcription System (Promega, Madi-
son, WI, USA) following the manufacturer’s instructions.
Oligos used
Library preparation: 3′ adaptor: 5′-AppTCG-
TATGCCGTCTTCTGCTTG-3′; 5′ adaptor: 5′-GUUCA-
GAGUUCUACAGUCCGACGAUC-3′.
RT primer/5′ PCR primer: 5′-CAAGCAGAA-
GACGGCATA-3′.
3′ PCR primer: 5′-AATGATACGGCGACCACCGA-
CAGGTTCAGAGTTCTACAGTCCGA-3′.
Polysome profiling: RPS23 forward: 5’-ACCCTTT
TGGAGGTGCTTCT-3’; RPS23 reverse: 5’-ATGACCT
TTGCGACCAAATC-3’; RPL23 forward: 5’-CTGACAA-
CACAGGAGCCAAA-3’; RPL23 reverse: 5’-ACACGCC
ATCTTTTCTACGG-3’; RPL34 forward: 5’-GAGGGG
TTCGTGCTGTAAGA-3’; RPL34 reverse: 5’-TCTGTGC
TTGTGCCTTCAAC-3’.
qRT-PCR SESN1 forward: 5′-GAGTCTTCGGATG
GGTTGAA-3′; SESN1 reverse: 5′-TGGTCCCTGTCCT
AGTGGTC-3′; SESN2 forward: 5′-TGCTGTGCTTTG
TGGAAGAC-3′; SESN2 reverse: 5′-GCTGCCTGGAA
CTTCTCATC-3′
Additional material
Additional file 1: Additional figures and legends to support our
data.
Additional file 2: Table S1: Ribo-Seq reads location and frame
distribution.
Additional file 3: Table S2: Genes whose transcripts showed a
change in either their expression level or in their translational
efficiency across the examined conditions. Cluster annotation (as in
Figure 1) is detailed.
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